Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6228 of 6351
-
Hospital staff learn healthy eating in new study
Knowledge-focused CompletedThis study was to investigate the effects of a health diet education program on improving nutrition knowledge, satisfaction, and dietary behavior among hospital staffs and volunteers.
Sponsor: En-Chi Chiu • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Oxygen sensor study halted early – what it means for patient monitoring
Knowledge-focused Stopped earlyValidation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Cancer surgery avoidance study withdrawn before it began
Disease control CancelledBackground: People with colorectal cancer (CRC) or gastroesophageal cancer (GEC) must often have major surgery to remove tumors from the esophagus, stomach, colon, or rectum. These surgeries can have adverse effects on their quality of life. Researchers want to know if one or tw…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC
-
New drug patch passes first safety check in healthy volunteers
Knowledge-focused CompletedThis Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics of a novel transdermal formulation of SFG-02 following single and repeated applications in Japanese and White healthy adult participants.
Phase 1 • Sponsor: Juro Sciences Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Healthy volunteers test new drug combo absorption
Knowledge-focused CompletedTo investigate the relative bioavailability of two different vicadrostat/empagliflozin combinations. Additionally, the trial investigates the effect of food on the pharmacokinetics of the vicadrostat/empagliflozin.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Generic vs. Brand-Name prostate drug: are they identical?
Knowledge-focused Recruiting nowThe aim of this study is to evaluate the bioequivalence and safety of Tamsulosin hydrochloride 0.4 mg, prolonged-release tablets (Synthon Hispania SL, Spain), compared to Omnic Ocas®, Tamsulosin hydrochloride 0.4 mg, prolonged-release film-coated tablets (Astellas Pharma Europe B…
Phase 1 • Sponsor: Berlin-Chemie AG Menarini Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Experimental blood pressure pill gets first safety check in humans
Knowledge-focused Recruiting nowThis is a randomized, double-blind, placebo-controlled, dose-escalation study in healthy Chinese subjects at single dose administration of Allisartan Isoproxil Tablets (240 mg ,480 mg or 720 mg)or placebo. The study design allows an assessment of 3 doses with safety monitoring an…
Phase 4 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:08 UTC
-
Healthy volunteers test generic vs. Brand-Name water pill
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the bioavailability, safety and tolerability of Torasemide 10 mg tablets (Berlin-Chemie AG), compared to Unat® 10 tablets (Viatris Healthcare GmbH) in healthy adult participants under fasting conditions.
Phase 1 • Sponsor: Berlin-Chemie AG Menarini Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Catheter study for lung blood clots pulled before it started
Disease control CancelledAssess the functionality of the Versus Catheter for catheter-directed thrombolysis of pulmonary blood clots, including advanced imaging assessment. An evaluation of patient outcomes from the cases included in this study will also be conducted.
Sponsor: Liquet Medical Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Probiotic safety check: will a daily capsule cause stomach trouble?
Knowledge-focused Not yet recruitingThe main objective of this project is to evaluate the absence of adverse gastrointestinal effects following the consumption of a daily probiotic capsule during 15 days. The secondary objective of this study is to verify the absence of any adverse effects other than gastrointesti…
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:45 UTC
-
New pain pill LTG-321 enters first human safety tests
Knowledge-focused CompletedThis is a first-in-human, randomized, double-blind, placebo-controlled Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of orally administered LTG-321 in healthy male…
Phase 1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Cancer combo trial pulled before it even started
Disease control CancelledTo apply its findings as rationale needed for a subsequent registration trial towards a novel indication for systemic treatment of resectable, lung-limited metastatic CRC.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug TBD09 tested for safety in healthy people
Knowledge-focused CompletedThis is a randomized, double-blind, placebo-controlled, multiple dose trial of TBD09, administered to healthy adult participants to assess safety, tolerability, and pharmacokinetics up to 84 days of fixed daily dosing of TBD09. The trial will be conducted with two cohorts, with p…
Phase 1 • Sponsor: Gates Medical Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Healthy volunteers help uncover drug interactions for FA treatment
Knowledge-focused CompletedIn this study, researchers will learn more about BIIB141, also known as omaveloxolone or SKYCLARYS®. This drug has been approved, or made available for doctors to prescribe, for people with Friedrich's Ataxia (FA) who are at least 16 years old. This is called a "drug-drug interac…
Phase 1 • Sponsor: Biogen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Hidden cost of cancer: study probes financial toxicity in sarcoma patients
Knowledge-focused Recruiting nowTo learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New drug ABBV-8736 tested in healthy people for first time
Knowledge-focused CompletedThe objective of this study is to assess the safety, tolerability, pharmacokinetics, and immunogenicity following multiple intravenous (IV) ascending doses of ABBV-8736 in healthy adult participants.
Phase 1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
3D printed vs. traditional aligners: which hosts more mouth bacteria?
Knowledge-focused CompletedThis study is being done to compare conventional clear aligners with 3D printed clear aligners to assess if there is any significant difference between the microbial colonization of these appliances. The 3D printed aligner material and conventional aligner materials are being use…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Healthy volunteers needed to test new Injection's safety
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the safety,tolerability and pharmacokinetics properties of KLA318-2 Nanocrystal Injection after a single intravenous injection in healthy participants.
Phase 1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New drug CM559 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis study is a single center, randomized, double-blind, placebo-controlled, single dose, dose escalation Phase I clinical study aimed at evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of CM559 administered intravenously at different d…
Phase 1 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Bite analysis tool gets a tray upgrade in small study
Knowledge-focused CompletedBackground: Occlusal contacts analysis is of prime importance in order to perform an effective prosthetic restoration. Quantitative methods for occlusal contact analysis involve using digital systems to measure and analyze occlusal contacts and forces with greater precision than …
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC